Detalhe da pesquisa
1.
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
N Engl J Med
; 385(21): 1941-1950, 2021 11 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34706189
2.
Constitutional de novo deletion CNV encompassing REST predisposes to diffuse hyperplastic perilobar nephroblastomatosis (HPLN).
J Med Genet
; 58(9): 581-585, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32917767
3.
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 327(13): 1236-1246, 2022 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35285853
4.
Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.
BMC Pulm Med
; 21(1): 154, 2021 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33964925
5.
Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.
Proc Natl Acad Sci U S A
; 115(49): E11485-E11494, 2018 12 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30442662
6.
Oral 5-Day Lefamulin for Outpatient Management of Community-Acquired Bacterial Pneumonia: Post-hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Trial.
J Emerg Med
; 60(6): 781-792, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33731270
7.
Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial.
JAMA
; 322(17): 1661-1671, 2019 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31560372
8.
Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30082292
9.
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
JAMA
; 319(8): 788-799, 2018 02 27.
Artigo
Inglês
| MEDLINE | ID: mdl-29486041
10.
Hierarchical expression of genes controlled by the Bacillus subtilis global regulatory protein CodY.
Proc Natl Acad Sci U S A
; 111(22): 8227-32, 2014 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-24843172
11.
Effects of fluconazole on the metabolomic profile of Candida albicans.
J Antimicrob Chemother
; 71(3): 635-40, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26668236
12.
Reply to Tang and Lai.
Clin Infect Dis
; 71(6): 1583, 2020 09 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31822883
13.
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
J Antimicrob Chemother
; 70(2): 470-8, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25288679
14.
Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives.
J Genet Couns
; 24(2): 300-11, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25315608
15.
Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers.
Clin Pharmacokinet
; 63(1): 57-68, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37955825
16.
Swinging at a cocktail party: voice familiarity aids speech perception in the presence of a competing voice.
Psychol Sci
; 24(10): 1995-2004, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23985575
17.
An Optimized Stress Granule Detection Method: Investigation of UBQLN2 Effect on Stress Granule Formation.
Methods Mol Biol
; 2551: 543-560, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36310224
18.
Population pharmacokinetics and exposure-response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID-19.
CPT Pharmacometrics Syst Pharmacol
; 12(6): 853-864, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36922886
19.
Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19.
J Patient Rep Outcomes
; 7(1): 92, 2023 09 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37702920
20.
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial.
Open Forum Infect Dis
; 10(7): ofad344, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37520411